Title:
New Alzheimer’s drug is 1st of its kind to be FDA approved
Published:
yahoo! news, 7 June 2021
From the article:
* In a major development for patients and the biotechnology industry, the U.S. Food and Drug Administration approved the use of a new drug, Aduhelm (aducanumab), for treating early Alzheimer’s disease.
* But the new drug, made by the biotechnology company Biogen, has been marred by controversy throughout its development history, with prominent Alzheimer's disease specialists arguing the drug's meager benefits are unlikely to outweigh the risk of serious side effects.